Global Governments Establish Regulatory and Ethical Standards for AI in Clinical Decision-Making
各國政府如何建立AI 臨床決策的監管與倫理標準? - TechNews 科技新報
Summary
Governments worldwide are shifting AI healthcare from unregulated technology use to formal institutional governance. The EU classifies clinical diagnosis as "high-risk" under its AI Act, the US mandates safety data sharing, and Taiwan's Ministry of Health and Welfare is standardizing FHIR and establishing a center for "Responsible AI" to ensure legal accountability and traceability.
Details
The regulatory push aims to overcome concerns regarding "black box" algorithms by establishing clear accountability and damage compensation mechanisms. The EU's AI Act requires strict pre-market review for high-risk areas like clinical diagnosis. The US mandates developers to share safety testing data via executive order. Taiwan is promoting FHIR standardization for electronic medical records and setting standards for cybersecurity and clinical evidence through its "Responsible AI Execution Center." This shift marks the entry of medical AI into a "legally accountable" era. Competition is moving beyond mere model accuracy toward managing compliance costs and accumulating Real-World Evidence (RWE). Future success requires cross-hospital collaboration, transparent decision trails, and third-party validation.
Original content copyright by respective publishers